| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.61e-08 | 11 | 165 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 6.83e-08 | 14 | 165 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 5.46e-07 | 37 | 165 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 6.45e-07 | 38 | 165 | 6 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.45e-07 | 38 | 165 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 6.63e-07 | 21 | 165 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN11A ABCA13 SLC26A4 TRPC4 SLC34A2 HTR3C SLC25A26 SLC9C2 SLC16A12 SLC22A12 GJA1 SLC8A2 SLC14A1 SLC22A16 ABCA5 ABCC8 KCNK15 ATP6V0A4 SLC9B2 TRPV4 CACNA1G GJC3 SVOP MFSD5 GABRA1 GABRA2 GABRA3 | 1.38e-06 | 1180 | 165 | 27 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SCN11A ABCA13 ESYT1 SLC26A4 TRPC4 SLC34A2 HTR3C SLC25A26 SLC9C2 SLC16A12 SLC22A12 GJA1 SLC8A2 SLC14A1 SLC22A16 ABCA5 ABCC8 KCNK15 ATP6V0A4 SLC9B2 TRPV4 CACNA1G GJC3 SVOP MFSD5 GABRA1 GABRA2 GABRA3 | 2.35e-06 | 1289 | 165 | 28 | GO:0005215 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.28e-05 | 37 | 165 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VN1R3 DRD5 OR2B2 FPR3 NPSR1 OR2G2 GPR78 HTR3C GPRC6A TAAR8 SSTR5 ITGAL PTGER2 OR1J4 OR6P1 PTH1R OR2A12 OXTR ABCC8 OR6C75 TRPV4 CCR8 ADGRL2 CX3CR1 GABRA1 GABRA2 GABRA3 | 1.71e-05 | 1353 | 165 | 27 | GO:0004888 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.78e-05 | 46 | 165 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | VN1R3 DRD5 OR2B2 FPR3 NPSR1 OR2G2 GPR78 GPRC6A TAAR8 SSTR5 PTGER2 OR1J4 OR6P1 PTH1R OR2A12 OXTR OR6C75 CCR8 ADGRL2 CX3CR1 | 4.33e-05 | 884 | 165 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 SMARCAL1 CHD9 CHD7 ERVK-7 ERVK-10 DCLRE1B REV3L ERVK-8 ERVK-11 | 6.70e-05 | 262 | 165 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 8.71e-05 | 11 | 165 | 3 | GO:0016303 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 8.71e-05 | 11 | 165 | 3 | GO:0008503 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 1.53e-04 | 33 | 165 | 4 | GO:0072349 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SCN11A SLC26A4 TRPC4 SLC34A2 SLC9C2 SLC8A2 SLC14A1 ABCC8 KCNK15 ATP6V0A4 SLC9B2 TRPV4 CACNA1G MFSD5 GABRA1 GABRA2 GABRA3 | 1.86e-04 | 758 | 165 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SCN11A SLC26A4 TRPC4 SLC34A2 HTR3C SLC9C2 GJA1 SLC8A2 ABCC8 KCNK15 ATP6V0A4 SLC9B2 TRPV4 CACNA1G GABRA1 GABRA2 GABRA3 | 3.14e-04 | 793 | 165 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.92e-04 | 75 | 165 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 4.13e-04 | 18 | 165 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | channel activity | SCN11A TRPC4 HTR3C GJA1 SLC14A1 ABCC8 KCNK15 TRPV4 CACNA1G GJC3 GABRA1 GABRA2 GABRA3 | 4.34e-04 | 525 | 165 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SCN11A TRPC4 HTR3C GJA1 SLC14A1 ABCC8 KCNK15 TRPV4 CACNA1G GJC3 GABRA1 GABRA2 GABRA3 | 4.41e-04 | 526 | 165 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 4.87e-04 | 19 | 165 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 4.99e-04 | 79 | 165 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 5.57e-04 | 123 | 165 | 6 | GO:0030165 | |
| GeneOntologyMolecularFunction | gap junction channel activity involved in cardiac conduction electrical coupling | 6.68e-04 | 5 | 165 | 2 | GO:0086075 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 6.68e-04 | 5 | 165 | 2 | GO:0030156 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 7.60e-04 | 22 | 165 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 8.40e-04 | 133 | 165 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 9.87e-04 | 24 | 165 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.10e-03 | 140 | 165 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.25e-03 | 26 | 165 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.26e-03 | 57 | 165 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.29e-03 | 316 | 165 | 9 | GO:0035091 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.39e-03 | 7 | 165 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | vasopressin receptor activity | 1.39e-03 | 7 | 165 | 2 | GO:0005000 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.45e-03 | 100 | 165 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.53e-03 | 60 | 165 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.67e-03 | 152 | 165 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.06e-03 | 65 | 165 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.06e-03 | 65 | 165 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA13 SLC26A4 SLC34A2 SLC25A26 SLC9C2 SLC16A12 SLC8A2 ABCA5 ABCC8 ATP6V0A4 SLC9B2 | 2.10e-03 | 477 | 165 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | gap junction channel activity involved in cell communication by electrical coupling | 2.35e-03 | 9 | 165 | 2 | GO:1903763 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 2.92e-03 | 10 | 165 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.01e-03 | 171 | 165 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.01e-03 | 171 | 165 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.50e-03 | 37 | 165 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 3.81e-03 | 77 | 165 | 4 | GO:0005230 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.54e-08 | 13 | 163 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.07e-06 | 48 | 163 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 4.24e-06 | 83 | 163 | 7 | GO:0006278 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN11A RELN SLC26A4 TRPC4 NPSR1 CDH23 SLC34A2 HTR3C CHD7 SLC25A26 SLC9C2 RGS7 SLC22A12 GJA1 SLC8A2 SLC22A16 PIK3C2A ABCC8 KCNK15 ATP6V0A4 SLC9B2 TRPV4 CACNA1G MFSD5 GABRA1 GABRA2 GABRA3 | 1.01e-05 | 1374 | 163 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | FPR3 PTGER2 PTH1R GJA1 SLC8A2 OXTR TRPV4 CACNA1G CCR8 CX3CR1 | 1.21e-05 | 224 | 163 | 10 | GO:0007204 |
| GeneOntologyBiologicalProcess | chronic inflammatory response | 4.18e-05 | 25 | 163 | 4 | GO:0002544 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 6.12e-05 | 218 | 163 | 9 | GO:0071897 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN11A RELN SLC26A4 TRPC4 NPSR1 SLC34A2 HTR3C CHD7 SLC9C2 RGS7 GJA1 SLC8A2 PIK3C2A ABCC8 KCNK15 ATP6V0A4 SLC9B2 TRPV4 CACNA1G GABRA1 GABRA2 GABRA3 | 6.91e-05 | 1115 | 163 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | reflex | 1.00e-04 | 31 | 163 | 4 | GO:0060004 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN11A SLC26A4 TRPC4 NPSR1 SLC34A2 HTR3C CHD7 SLC9C2 RGS7 SLC8A2 PIK3C2A ABCC8 KCNK15 ATP6V0A4 SLC9B2 TRPV4 CACNA1G GABRA1 GABRA2 GABRA3 | 1.58e-04 | 1017 | 163 | 20 | GO:0098660 |
| GeneOntologyCellularComponent | brush border membrane | 4.05e-06 | 83 | 164 | 7 | GO:0031526 | |
| GeneOntologyCellularComponent | brush border | 2.72e-05 | 152 | 164 | 8 | GO:0005903 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | FLII DRD5 SLC26A4 CDH23 SLC34A2 PTH1R SLC22A12 ATP6V0A4 ENPEP | 6.90e-05 | 223 | 164 | 9 | GO:0098862 |
| GeneOntologyCellularComponent | cell projection membrane | PSD2 DRD5 SLC26A4 SLC34A2 PTH1R SLC22A12 ATP6V0A4 TRPV4 ENPEP GABRA1 GABRA2 GABRA3 | 1.58e-04 | 431 | 164 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | apical part of cell | SLC26A4 SPTBN2 CDH23 SLC34A2 SRR PTH1R SLC22A12 GJA1 OXTR ATP6V0A4 SLC9B2 BYSL TRPV4 ENPEP | 2.46e-04 | 592 | 164 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 4.19e-04 | 19 | 164 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 5.01e-04 | 47 | 164 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | GABA receptor complex | 5.68e-04 | 21 | 164 | 3 | GO:1902710 | |
| Domain | SCAN | ZSCAN31 SCAND2P ZKSCAN2 ZKSCAN7 ZNF215 ZNF397 ZSCAN29 ZSCAN20 ZNF394 ZKSCAN4 ZSCAN23 ZNF445 | 3.30e-14 | 56 | 157 | 12 | SM00431 |
| Domain | SCAN_BOX | ZSCAN31 SCAND2P ZKSCAN2 ZKSCAN7 ZNF215 ZNF397 ZSCAN29 ZSCAN20 ZNF394 ZKSCAN4 ZSCAN23 ZNF445 | 5.20e-14 | 58 | 157 | 12 | PS50804 |
| Domain | SCAN | ZSCAN31 SCAND2P ZKSCAN2 ZKSCAN7 ZNF215 ZNF397 ZSCAN29 ZSCAN20 ZNF394 ZKSCAN4 ZSCAN23 ZNF445 | 5.20e-14 | 58 | 157 | 12 | PF02023 |
| Domain | SCAN_dom | ZSCAN31 SCAND2P ZKSCAN2 ZKSCAN7 ZNF215 ZNF397 ZSCAN29 ZSCAN20 ZNF394 ZKSCAN4 ZSCAN23 ZNF445 | 5.20e-14 | 58 | 157 | 12 | IPR003309 |
| Domain | Retrov_capsid_C | ERVK-6 ZSCAN31 ZKSCAN2 ZKSCAN7 ZNF215 ZNF397 ZSCAN29 ZSCAN20 ZNF394 ZKSCAN4 ZSCAN23 ZNF445 | 6.48e-14 | 59 | 157 | 12 | IPR008916 |
| Domain | Anaphylatoxin_comp_syst | 5.76e-06 | 5 | 157 | 3 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 5.76e-06 | 5 | 157 | 3 | IPR001840 | |
| Domain | GABAAa_rcpt | 1.14e-05 | 6 | 157 | 3 | IPR001390 | |
| Domain | ANATO | 1.99e-05 | 7 | 157 | 3 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 1.99e-05 | 7 | 157 | 3 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.99e-05 | 7 | 157 | 3 | PS01177 | |
| Domain | ANATO | 1.99e-05 | 7 | 157 | 3 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.99e-05 | 7 | 157 | 3 | IPR000020 | |
| Domain | G_PROTEIN_RECEP_F1_1 | VN1R3 DRD5 OR2B2 FPR3 NPSR1 OR2G2 GPR78 TAAR8 SSTR5 PTGER2 OR1J4 OR6P1 OR2A12 OXTR OR6C75 CCR8 CX3CR1 | 6.61e-05 | 685 | 157 | 17 | PS00237 |
| Domain | A2M | 6.70e-05 | 10 | 157 | 3 | PF00207 | |
| Domain | A2M_N_2 | 6.70e-05 | 10 | 157 | 3 | IPR011625 | |
| Domain | A2M_comp | 6.70e-05 | 10 | 157 | 3 | IPR011626 | |
| Domain | A2M_recep | 6.70e-05 | 10 | 157 | 3 | PF07677 | |
| Domain | A2M_comp | 6.70e-05 | 10 | 157 | 3 | PF07678 | |
| Domain | A2M_N | 6.70e-05 | 10 | 157 | 3 | PF01835 | |
| Domain | A2M_N | 6.70e-05 | 10 | 157 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 6.70e-05 | 10 | 157 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 6.70e-05 | 10 | 157 | 3 | PS00477 | |
| Domain | A2M_N_2 | 6.70e-05 | 10 | 157 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 6.70e-05 | 10 | 157 | 3 | IPR001599 | |
| Domain | G_PROTEIN_RECEP_F1_2 | VN1R3 DRD5 OR2B2 FPR3 NPSR1 OR2G2 GPR78 TAAR8 SSTR5 PTGER2 OR1J4 OR6P1 OR2A12 OXTR OR6C75 CCR8 CX3CR1 | 7.36e-05 | 691 | 157 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | VN1R3 DRD5 OR2B2 FPR3 NPSR1 OR2G2 GPR78 TAAR8 SSTR5 PTGER2 OR1J4 OR6P1 OR2A12 OXTR OR6C75 CCR8 CX3CR1 | 7.49e-05 | 692 | 157 | 17 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | DRD5 OR2B2 FPR3 NPSR1 OR2G2 GPR78 TAAR8 SSTR5 PTGER2 OR1J4 OR6P1 OR2A12 OXTR OR6C75 CCR8 CX3CR1 | 1.70e-04 | 670 | 157 | 16 | IPR017452 |
| Domain | 7tm_1 | DRD5 OR2B2 FPR3 NPSR1 OR2G2 GPR78 TAAR8 SSTR5 PTGER2 OR1J4 OR6P1 OR2A12 OXTR OR6C75 CCR8 CX3CR1 | 1.91e-04 | 677 | 157 | 16 | PF00001 |
| Domain | PI3/4_kinase_CS | 2.46e-04 | 15 | 157 | 3 | IPR018936 | |
| Domain | - | 3.01e-04 | 16 | 157 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.01e-04 | 16 | 157 | 3 | SM00146 | |
| Domain | C345C | 3.63e-04 | 17 | 157 | 3 | SM00643 | |
| Domain | PstgldnD_synth | 4.17e-04 | 4 | 157 | 2 | IPR002972 | |
| Domain | - | 4.17e-04 | 4 | 157 | 2 | 1.20.91.20 | |
| Domain | PI3_PI4_kinase | 4.33e-04 | 18 | 157 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 4.33e-04 | 18 | 157 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.33e-04 | 18 | 157 | 3 | PS00916 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.33e-04 | 18 | 157 | 3 | IPR008930 | |
| Domain | PI3/4_kinase_cat_dom | 4.33e-04 | 18 | 157 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 4.33e-04 | 18 | 157 | 3 | PS50290 | |
| Domain | NTR | 5.11e-04 | 19 | 157 | 3 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 5.11e-04 | 19 | 157 | 3 | IPR018933 | |
| Domain | PRAME_family | 5.11e-04 | 19 | 157 | 3 | IPR026271 | |
| Domain | Neurotransmitter_ion_chnl_CS | 5.48e-04 | 45 | 157 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 5.96e-04 | 46 | 157 | 4 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 6.47e-04 | 47 | 157 | 4 | IPR006029 | |
| Domain | - | 6.47e-04 | 47 | 157 | 4 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 6.47e-04 | 47 | 157 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 6.47e-04 | 47 | 157 | 4 | PS00236 | |
| Domain | Neur_channel | 6.47e-04 | 47 | 157 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 6.47e-04 | 47 | 157 | 4 | IPR006202 | |
| Domain | Vasoprsn_rcpt | 6.91e-04 | 5 | 157 | 2 | IPR001817 | |
| Domain | GABAA/Glycine_rcpt | 9.12e-04 | 23 | 157 | 3 | IPR006028 | |
| Domain | NTR | 9.12e-04 | 23 | 157 | 3 | PS50189 | |
| Domain | Netrin_domain | 9.12e-04 | 23 | 157 | 3 | IPR001134 | |
| Domain | BRK | 1.03e-03 | 6 | 157 | 2 | SM00592 | |
| Domain | L6_membrane | 1.03e-03 | 6 | 157 | 2 | IPR008661 | |
| Domain | BRK_domain | 1.03e-03 | 6 | 157 | 2 | IPR006576 | |
| Domain | L6_membrane | 1.03e-03 | 6 | 157 | 2 | PF05805 | |
| Domain | BRK | 1.03e-03 | 6 | 157 | 2 | PF07533 | |
| Domain | TIMP-like_OB-fold | 1.31e-03 | 26 | 157 | 3 | IPR008993 | |
| Domain | PI3K_Ras-bd_dom | 1.43e-03 | 7 | 157 | 2 | IPR000341 | |
| Domain | Somatotropin | 1.43e-03 | 7 | 157 | 2 | IPR001400 | |
| Domain | PI3K_rbd | 1.43e-03 | 7 | 157 | 2 | SM00144 | |
| Domain | PI3K_rbd | 1.43e-03 | 7 | 157 | 2 | PF00794 | |
| Domain | SWIM | 1.43e-03 | 7 | 157 | 2 | PF04434 | |
| Domain | PI3K_RBD | 1.43e-03 | 7 | 157 | 2 | PS51546 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.90e-03 | 8 | 157 | 2 | IPR019565 | |
| Domain | PI3K_C2 | 1.90e-03 | 8 | 157 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 1.90e-03 | 8 | 157 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 1.90e-03 | 8 | 157 | 2 | PF00792 | |
| Domain | Thiol-ester_cl | 1.90e-03 | 8 | 157 | 2 | PF10569 | |
| Domain | PI3K_C2 | 1.90e-03 | 8 | 157 | 2 | PS51547 | |
| Domain | MacrogloblnA2_CS | 1.90e-03 | 8 | 157 | 2 | IPR019742 | |
| Domain | A2M_N_2 | 1.90e-03 | 8 | 157 | 2 | SM01359 | |
| Domain | - | 1.90e-03 | 8 | 157 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 1.90e-03 | 8 | 157 | 2 | SM01361 | |
| Domain | A2M | 1.90e-03 | 8 | 157 | 2 | SM01360 | |
| Domain | MFS | 2.19e-03 | 108 | 157 | 5 | PS50850 | |
| Domain | SNF2_N | 2.42e-03 | 32 | 157 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.42e-03 | 32 | 157 | 3 | PF00176 | |
| Domain | PI3Ka | 2.43e-03 | 9 | 157 | 2 | PF00613 | |
| Domain | PH_dom-spectrin-type | 2.43e-03 | 9 | 157 | 2 | IPR001605 | |
| Domain | PI3Ka | 2.43e-03 | 9 | 157 | 2 | SM00145 | |
| Domain | ZF_SWIM | 2.43e-03 | 9 | 157 | 2 | PS50966 | |
| Domain | Znf_SWIM | 2.43e-03 | 9 | 157 | 2 | IPR007527 | |
| Domain | - | 2.43e-03 | 9 | 157 | 2 | 1.25.40.70 | |
| Domain | CAP_GLY | 3.02e-03 | 10 | 157 | 2 | PF01302 | |
| Domain | CAP_GLY | 3.02e-03 | 10 | 157 | 2 | SM01052 | |
| Domain | PI_Kinase | 3.02e-03 | 10 | 157 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 3.02e-03 | 10 | 157 | 2 | IPR001263 | |
| Domain | - | 3.02e-03 | 10 | 157 | 2 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 3.02e-03 | 10 | 157 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 3.02e-03 | 10 | 157 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 3.02e-03 | 10 | 157 | 2 | IPR000938 | |
| Domain | PIK_HELICAL | 3.02e-03 | 10 | 157 | 2 | PS51545 | |
| Domain | MFS_sugar_transport-like | 3.39e-03 | 36 | 157 | 3 | IPR005828 | |
| Domain | Sugar_tr | 3.39e-03 | 36 | 157 | 3 | PF00083 | |
| Domain | TRP_channel | 3.67e-03 | 11 | 157 | 2 | IPR004729 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | DRD5 FPR3 TAAR8 SSTR5 PTGER2 PTH1R GH2 OXTR GABRA1 GABRA2 GABRA3 | 8.88e-06 | 272 | 110 | 11 | M13380 |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 1.58e-05 | 7 | 110 | 3 | MM14685 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 2.52e-05 | 8 | 110 | 3 | M27031 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 3.75e-05 | 9 | 110 | 3 | M22034 | |
| Pathway | WP_GPCRS_NONODORANT | DRD5 NPSR1 GPRC6A SSTR5 PTGER2 PTH1R OXTR CCR8 ADGRL2 CX3CR1 | 4.32e-05 | 266 | 110 | 10 | MM15843 |
| Pathway | BIOCARTA_GABA_PATHWAY | 5.33e-05 | 10 | 110 | 3 | M477 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 5.33e-05 | 10 | 110 | 3 | MM1401 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 7.29e-05 | 11 | 110 | 3 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 9.66e-05 | 12 | 110 | 3 | MM1368 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.25e-04 | 13 | 110 | 3 | M4732 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD5 FPR3 NPSR1 GPRC6A TAAR8 SSTR5 PTGER2 PTH1R OXTR CCR8 C5 CX3CR1 | 1.31e-04 | 430 | 110 | 12 | MM15160 |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.96e-04 | 15 | 110 | 3 | M7146 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.13e-04 | 70 | 110 | 5 | MM15959 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.55e-04 | 330 | 110 | 10 | M18334 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD5 FPR3 NPSR1 GPRC6A TAAR8 SSTR5 PTGER2 PTH1R OXTR CCR8 C5 CX3CR1 | 2.60e-04 | 463 | 110 | 12 | M507 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.74e-04 | 333 | 110 | 10 | MM14963 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 2.90e-04 | 17 | 110 | 3 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.90e-04 | 17 | 110 | 3 | MM1369 | |
| Pathway | WP_PEPTIDE_GPCRS | 2.95e-04 | 75 | 110 | 5 | M39696 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 4.78e-04 | 20 | 110 | 3 | M917 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ESYT1 SLC26A4 TRPC4 SLC34A2 SLC25A26 SLC9C2 SLC22A12 SLC8A2 SLC14A1 SLC22A16 ABCA5 LCN15 ATP6V0A4 SLC9B2 TRPV4 | 5.82e-04 | 736 | 110 | 15 | M27287 |
| Pathway | WP_COMPLEMENT_ACTIVATION | 6.39e-04 | 22 | 110 | 3 | M39502 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC26A4 SLC34A2 SLC25A26 SLC22A12 SLC8A2 SLC14A1 SLC22A16 LCN15 | 7.36e-04 | 249 | 110 | 8 | M5988 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 8.85e-04 | 197 | 110 | 7 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 8.85e-04 | 197 | 110 | 7 | MM14970 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 9.74e-04 | 260 | 110 | 8 | M39397 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD5 FPR3 NPSR1 GPRC6A TAAR8 SSTR5 PTGER2 RGS7 PTH1R OXTR CCR8 C5 CX3CR1 | 1.55e-03 | 646 | 110 | 13 | MM14962 |
| Pubmed | 1.86e-08 | 7 | 169 | 4 | 35228700 | ||
| Pubmed | 1.10e-07 | 10 | 169 | 4 | 36733270 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 15017002 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 16835366 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 15304513 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 1356407 | ||
| Pubmed | Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity. | 1.13e-07 | 3 | 169 | 3 | 8649451 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 4.05e-07 | 94 | 169 | 7 | 21542922 | |
| Pubmed | Impaired mast cell-dependent natural immunity in complement C3-deficient mice. | 4.49e-07 | 4 | 169 | 3 | 9367154 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 26518133 | ||
| Pubmed | Phylogeny of the C3/C4/C5 complement-component gene family indicates that C5 diverged first. | 4.49e-07 | 4 | 169 | 3 | 8015436 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 25865415 | ||
| Pubmed | Early reduction of microglia activation by irradiation in a model of chronic glaucoma. | 4.49e-07 | 4 | 169 | 3 | 22952717 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 25080596 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.49e-07 | 4 | 169 | 3 | 10469592 | |
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 4.49e-07 | 4 | 169 | 3 | 18821008 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.12e-06 | 5 | 169 | 3 | 12629516 | |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 15192652 | ||
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 17200182 | ||
| Pubmed | Predominant role for C5b-9 in renal ischemia/reperfusion injury. | 1.12e-06 | 5 | 169 | 3 | 10811844 | |
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 1.12e-06 | 5 | 169 | 3 | 30104684 | |
| Pubmed | Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency. | 1.12e-06 | 5 | 169 | 3 | 25039245 | |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 29743491 | ||
| Pubmed | Formation of high affinity C5 convertase of the classical pathway of complement. | 1.12e-06 | 5 | 169 | 3 | 12878586 | |
| Pubmed | 1.56e-06 | 18 | 169 | 4 | 18664271 | ||
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 2.23e-06 | 6 | 169 | 3 | 15033447 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 16849499 | ||
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 20457185 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 3.89e-06 | 7 | 169 | 3 | 20843900 | |
| Pubmed | Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. | 3.89e-06 | 7 | 169 | 3 | 14660741 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 16101898 | ||
| Pubmed | 4.43e-06 | 23 | 169 | 4 | 19480014 | ||
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 24474777 | ||
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 8175718 | ||
| Pubmed | The role of complement in cryoglobulin-induced immune complex glomerulonephritis. | 6.20e-06 | 8 | 169 | 3 | 16272350 | |
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 28301559 | ||
| Pubmed | Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping. | 6.20e-06 | 8 | 169 | 3 | 30173917 | |
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 11528422 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 1.32e-05 | 10 | 169 | 3 | 21789198 | |
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 30429287 | ||
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 1.81e-05 | 11 | 169 | 3 | 9924185 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 1.81e-05 | 11 | 169 | 3 | 38894703 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.35e-05 | 2 | 169 | 2 | 16565498 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 15998580 | ||
| Pubmed | T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor. | 2.35e-05 | 2 | 169 | 2 | 20547167 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.35e-05 | 2 | 169 | 2 | 19933335 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22763624 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.35e-05 | 2 | 169 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.35e-05 | 2 | 169 | 2 | 17645767 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12207352 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 35809029 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.35e-05 | 2 | 169 | 2 | 27758680 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.35e-05 | 2 | 169 | 2 | 23749435 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.35e-05 | 2 | 169 | 2 | 3037333 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21621520 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11726230 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21875659 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.35e-05 | 2 | 169 | 2 | 6950384 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23147414 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23109109 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.35e-05 | 2 | 169 | 2 | 8428773 | |
| Pubmed | TRPV4 channels augment macrophage activation and ventilator-induced lung injury. | 2.35e-05 | 2 | 169 | 2 | 20562229 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24638111 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22666188 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.35e-05 | 2 | 169 | 2 | 21345967 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 19617313 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2572548 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2302180 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 2.35e-05 | 2 | 169 | 2 | 18091514 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 29080553 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 8391122 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 2.35e-05 | 2 | 169 | 2 | 25339671 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17728371 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6149580 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6149581 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12115608 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 3542363 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 2387317 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 1664786 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18973555 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16908004 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 7365238 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 7391573 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 2.35e-05 | 2 | 169 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 2.35e-05 | 2 | 169 | 2 | 17971229 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 6881182 | ||
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 2.35e-05 | 2 | 169 | 2 | 18202657 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 2.35e-05 | 2 | 169 | 2 | 17921792 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 2.35e-05 | 2 | 169 | 2 | 6978711 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 35898513 | ||
| Interaction | ZSCAN32 interactions | ZSCAN12 ZKSCAN2 ZKSCAN7 ZNF397 ZSCAN29 ZSCAN20 ZNF394 ZKSCAN4 ZSCAN23 | 3.88e-11 | 45 | 150 | 9 | int:ZSCAN32 |
| Interaction | ZSCAN20 interactions | 2.75e-08 | 65 | 150 | 8 | int:ZSCAN20 | |
| Interaction | SCAND1 interactions | ZSCAN12 ZKSCAN7 ZNF215 ZNF397 ZSCAN20 ZNF394 ZKSCAN4 ZSCAN23 | 4.99e-08 | 70 | 150 | 8 | int:SCAND1 |
| Interaction | ZSCAN22 interactions | 1.74e-07 | 34 | 150 | 6 | int:ZSCAN22 | |
| Interaction | ZNF446 interactions | 3.03e-07 | 88 | 150 | 8 | int:ZNF446 | |
| Interaction | ZSCAN23 interactions | 4.10e-07 | 39 | 150 | 6 | int:ZSCAN23 | |
| Interaction | PGBD1 interactions | 2.20e-06 | 29 | 150 | 5 | int:PGBD1 | |
| Interaction | ZNF232 interactions | 2.36e-06 | 52 | 150 | 6 | int:ZNF232 | |
| Interaction | ZSCAN30 interactions | 3.78e-06 | 15 | 150 | 4 | int:ZSCAN30 | |
| Interaction | SCAND3 interactions | 5.01e-06 | 16 | 150 | 4 | int:SCAND3 | |
| Interaction | ZNF397 interactions | 6.71e-06 | 62 | 150 | 6 | int:ZNF397 | |
| Interaction | ZKSCAN7 interactions | 1.05e-05 | 19 | 150 | 4 | int:ZKSCAN7 | |
| Interaction | ZNF396 interactions | 2.34e-05 | 23 | 150 | 4 | int:ZNF396 | |
| Interaction | ZSCAN29 interactions | 4.53e-05 | 27 | 150 | 4 | int:ZSCAN29 | |
| Interaction | ZKSCAN3 interactions | 5.25e-05 | 28 | 150 | 4 | int:ZKSCAN3 | |
| Interaction | ZNF394 interactions | 1.09e-04 | 13 | 150 | 3 | int:ZNF394 | |
| Cytoband | 3p21.32 | 1.34e-04 | 5 | 169 | 2 | 3p21.32 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.84e-05 | 9 | 111 | 3 | 1234 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 7.60e-05 | 37 | 111 | 4 | 454 | |
| GeneFamily | Solute carriers | SLC26A4 SLC34A2 SLC25A26 SLC9C2 SLC16A12 SLC22A12 SLC8A2 SLC14A1 SLC22A16 SLC9B2 | 1.60e-04 | 395 | 111 | 10 | 752 |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 2.03e-04 | 19 | 111 | 3 | 563 | |
| GeneFamily | PRAME family | 4.15e-04 | 24 | 111 | 3 | 686 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 1.02e-03 | 8 | 111 | 2 | 831 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 1.31e-03 | 9 | 111 | 2 | 90 | |
| GeneFamily | Complement system|Sushi domain containing | 1.39e-03 | 36 | 111 | 3 | 492 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZSCAN12 ZSCAN31 ZKSCAN2 ZKSCAN7 ZNF215 ZNF397 ZSCAN29 ZSCAN20 ZNF394 ZKSCAN4 ZSCAN23 ZNF445 | 1.52e-03 | 718 | 111 | 12 | 28 |
| GeneFamily | ATP binding cassette subfamily A | 3.24e-03 | 14 | 111 | 2 | 805 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.22e-03 | 53 | 111 | 3 | 532 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 5.36e-03 | 18 | 111 | 2 | 1160 | |
| GeneFamily | Lipocalins | 5.97e-03 | 19 | 111 | 2 | 631 | |
| GeneFamily | Gap junction proteins | 7.96e-03 | 22 | 111 | 2 | 314 | |
| GeneFamily | Transient receptor potential cation channels | 1.27e-02 | 28 | 111 | 2 | 249 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | RELN PSD2 DRD5 SPTBN2 SLC34A2 SSTR5 SLC8A2 OXTR MIXL1 ABCC8 KCNK15 SLIT1 CACNA1G | 2.74e-06 | 438 | 158 | 13 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | RELN PSD2 DRD5 SPTBN2 SLC34A2 SSTR5 SLC8A2 OXTR MIXL1 ABCC8 KCNK15 SLIT1 CACNA1G | 2.88e-06 | 440 | 158 | 13 | MM832 |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.47e-07 | 191 | 159 | 8 | 6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.83e-07 | 193 | 159 | 8 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.01e-07 | 136 | 159 | 7 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.01e-07 | 136 | 159 | 7 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.21e-06 | 151 | 159 | 7 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.20e-06 | 182 | 159 | 7 | 27a27a3eaeacb087c9601d5bb1c9e57cdfcd9d77 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-06 | 184 | 159 | 7 | 92314fcdb74c0a1262c9334c774819a2a49ba454 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.76e-06 | 191 | 159 | 7 | 9b8b64a36e27a2523b8730c7922fd7ad865a021e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.96e-06 | 192 | 159 | 7 | 0b506fb5bca54a50949932293c6f86d974a3acdd | |
| ToppCell | Immune-natural_killer_cell|World / Lineage, Cell type, age group and donor | 5.96e-06 | 192 | 159 | 7 | 68121a6ef4115a93d87aad8802ef9b27d793d8c0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-06 | 193 | 159 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.05e-06 | 197 | 159 | 7 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.05e-06 | 197 | 159 | 7 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 7.78e-06 | 200 | 159 | 7 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-05 | 150 | 159 | 6 | 6785b695a01de47a47f5c94fdc432428ef80bada | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-05 | 150 | 159 | 6 | ddfb7dd696f06e834c45d6c3f9b1138bc17d62b3 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-05 | 154 | 159 | 6 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-05 | 154 | 159 | 6 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-05 | 162 | 159 | 6 | 9f568836199a05f696294caac1ea3fa413984423 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Nrp2_(Anterior_thalamus)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.59e-05 | 48 | 159 | 4 | 0553da597a3c02ab3ccdcd9aafda89dc6f8bfb20 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 2.95e-05 | 166 | 159 | 6 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-05 | 171 | 159 | 6 | fa5cc720bd0045d0307439be547b41d56def5b43 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.60e-05 | 172 | 159 | 6 | 2651dece87c3e3d2d6370f5274ebae357474b825 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-05 | 174 | 159 | 6 | 019eae059bd9eb107dee8f0d0f574ca36c2c26e1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-05 | 175 | 159 | 6 | 24651f95540ea2c8f3720aa943cbdd15661ee3fa | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 176 | 159 | 6 | 096cbcefd9dcbaee660568998ba210253b58501e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 176 | 159 | 6 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 176 | 159 | 6 | da5933eb253f13e70296a50a2bb00ad5c19a2d99 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 176 | 159 | 6 | 90198fb79e8b08e9e7df538cbc05ad7141e78517 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.22e-05 | 177 | 159 | 6 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.22e-05 | 177 | 159 | 6 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-05 | 182 | 159 | 6 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 183 | 159 | 6 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.24e-05 | 184 | 159 | 6 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-05 | 184 | 159 | 6 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.24e-05 | 184 | 159 | 6 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 5.40e-05 | 185 | 159 | 6 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-05 | 186 | 159 | 6 | 2fab7abed16a894afdd0207e86fc43a25a77fb9e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-05 | 186 | 159 | 6 | ea2c8e0df038a00062d2098b4a9ac85141b9a728 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-05 | 186 | 159 | 6 | 714765585a644bf9817ab6eb3001b43b3c2d2410 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 187 | 159 | 6 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 187 | 159 | 6 | b7689e7f6511920cd2beff27389555fddf685f61 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 5.90e-05 | 188 | 159 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.44e-05 | 191 | 159 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.63e-05 | 192 | 159 | 6 | 92f141d5ac462f652f405efa73ac6ef751f40ea3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-05 | 192 | 159 | 6 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.63e-05 | 192 | 159 | 6 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-05 | 194 | 159 | 6 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.02e-05 | 194 | 159 | 6 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | COVID-19-lung-NK_cells|lung / Disease (COVID-19 only), tissue and cell type | 7.22e-05 | 195 | 159 | 6 | 3b716ec7acc9a37af6bf40e711a539ce58d74aa4 | |
| ToppCell | COVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type | 7.22e-05 | 195 | 159 | 6 | 3ab941a369e3815f338890b116dc77aefa054098 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.86e-05 | 198 | 159 | 6 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.86e-05 | 198 | 159 | 6 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.08e-05 | 199 | 159 | 6 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.31e-05 | 200 | 159 | 6 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.31e-05 | 200 | 159 | 6 | bfbd2ccf4b28901aad63d70a382a8247e4458ba6 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Proliferative_Immature_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.24e-04 | 135 | 159 | 5 | ed0f94d3839eea3b60217c4352159ed481361f13 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 137 | 159 | 5 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 137 | 159 | 5 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 137 | 159 | 5 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| Drug | Zolpidem | 3.47e-07 | 3 | 161 | 3 | DB00425 | |
| Drug | Flumazenil | 1.38e-06 | 4 | 161 | 3 | DB01205 | |
| Drug | Eszopiclone | 3.43e-06 | 5 | 161 | 3 | DB00402 | |
| Drug | Zopiclone | 3.43e-06 | 5 | 161 | 3 | DB01198 | |
| Drug | Lorazepam | 3.43e-06 | 5 | 161 | 3 | ctd:D008140 | |
| Drug | Meprobamate | 6.83e-06 | 6 | 161 | 3 | DB00371 | |
| Drug | Quazepam | 1.19e-05 | 7 | 161 | 3 | DB01589 | |
| Drug | AC1L8TD1 | 1.19e-05 | 7 | 161 | 3 | CID000407799 | |
| Drug | Adinazolam | 1.89e-05 | 8 | 161 | 3 | DB00546 | |
| Drug | Fludiazepam | 1.89e-05 | 8 | 161 | 3 | DB01567 | |
| Drug | Clotiazepam | 1.89e-05 | 8 | 161 | 3 | DB01559 | |
| Drug | Cinolazepam | 1.89e-05 | 8 | 161 | 3 | DB01594 | |
| Drug | Prazepam | 1.89e-05 | 8 | 161 | 3 | DB01588 | |
| Drug | Estazolam | 1.89e-05 | 8 | 161 | 3 | DB01215 | |
| Drug | Halazepam | 1.89e-05 | 8 | 161 | 3 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 1.89e-05 | 8 | 161 | 3 | ctd:C091518 | |
| Drug | Ethchlorvynol | 2.83e-05 | 9 | 161 | 3 | DB00189 | |
| Drug | Diazepam | 2.83e-05 | 9 | 161 | 3 | DB00829 | |
| Drug | tiotidine | 2.83e-05 | 9 | 161 | 3 | ctd:C023990 | |
| Drug | Secobarbital | 4.02e-05 | 10 | 161 | 3 | DB00418 | |
| Drug | Chlordiazepoxide | 4.02e-05 | 10 | 161 | 3 | DB00475 | |
| Drug | Metharbital | 4.02e-05 | 10 | 161 | 3 | DB00463 | |
| Drug | Pentobarbital | 4.02e-05 | 10 | 161 | 3 | DB00312 | |
| Drug | Talbutal | 4.02e-05 | 10 | 161 | 3 | DB00306 | |
| Drug | Clobazam | 4.02e-05 | 10 | 161 | 3 | DB00349 | |
| Drug | Butalbital | 4.02e-05 | 10 | 161 | 3 | DB00241 | |
| Drug | Butabarbital | 4.02e-05 | 10 | 161 | 3 | DB00237 | |
| Drug | Bromazepam | 4.02e-05 | 10 | 161 | 3 | DB01558 | |
| Drug | Barbituric acid derivative | 4.02e-05 | 10 | 161 | 3 | DB01496 | |
| Drug | Barbital | 4.02e-05 | 10 | 161 | 3 | DB01483 | |
| Drug | Hexobarbital | 4.02e-05 | 10 | 161 | 3 | DB01355 | |
| Drug | Aprobarbital | 4.02e-05 | 10 | 161 | 3 | DB01352 | |
| Drug | Amobarbital | 4.02e-05 | 10 | 161 | 3 | DB01351 | |
| Drug | Heptabarbital | 4.02e-05 | 10 | 161 | 3 | DB01354 | |
| Drug | Butethal | 4.02e-05 | 10 | 161 | 3 | DB01353 | |
| Drug | Methylphenobarbital | 4.02e-05 | 10 | 161 | 3 | DB00849 | |
| Drug | Oxazepam | 4.02e-05 | 10 | 161 | 3 | DB00842 | |
| Drug | Primidone | 4.02e-05 | 10 | 161 | 3 | DB00794 | |
| Drug | Midazolam | 4.02e-05 | 10 | 161 | 3 | DB00683 | |
| Drug | Flurazepam | 4.02e-05 | 10 | 161 | 3 | DB00690 | |
| Drug | Clonazepam | 4.02e-05 | 10 | 161 | 3 | DB01068 | |
| Drug | N-(all-trans-retinoyl)-DL-leucine | 4.97e-05 | 2 | 161 | 2 | CID006439237 | |
| Drug | retinoylglycine | 4.97e-05 | 2 | 161 | 2 | CID005379396 | |
| Drug | Thiopental | 5.49e-05 | 11 | 161 | 3 | DB00599 | |
| Drug | Alprazolam | 5.49e-05 | 11 | 161 | 3 | DB00404 | |
| Drug | Temazepam | 5.49e-05 | 11 | 161 | 3 | DB00231 | |
| Drug | Nitrazepam | 5.49e-05 | 11 | 161 | 3 | DB01595 | |
| Drug | Lorazepam | 5.49e-05 | 11 | 161 | 3 | DB00186 | |
| Drug | Phenobarbital | 5.49e-05 | 11 | 161 | 3 | DB01174 | |
| Drug | Triazolam | 5.49e-05 | 11 | 161 | 3 | DB00897 | |
| Drug | Clorazepate | 5.49e-05 | 11 | 161 | 3 | DB00628 | |
| Drug | UDP-glucose | 6.86e-05 | 247 | 161 | 9 | CID000001166 | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 7.98e-05 | 196 | 161 | 8 | 5521_DN | |
| Drug | CGS 8216 | 8.40e-05 | 33 | 161 | 4 | CID000104916 | |
| Drug | 2-aminothiophenol | 1.48e-04 | 3 | 161 | 2 | ctd:C005464 | |
| Disease | Autistic Disorder | 9.75e-07 | 261 | 150 | 10 | C0004352 | |
| Disease | anxiety, stress-related disorder, major depressive disorder | 3.68e-06 | 46 | 150 | 5 | EFO_0005230, EFO_0010098, MONDO_0002009 | |
| Disease | Immunologic Deficiency Syndromes | 5.27e-06 | 23 | 150 | 4 | C0021051 | |
| Disease | metabolite measurement | ABO SRR REV3L WDFY4 SLC22A12 TBC1D13 ZNF394 NAPRT CLVS2 HAO2 ENPEP | 1.45e-04 | 560 | 150 | 11 | EFO_0004725 |
| Disease | Schizophrenia | RELN ZSCAN31 ABCA13 SPTBN2 NPSR1 GPR78 SRR CFAP65 OXTR CLVS2 ERVK-8 ATM ZKSCAN4 GABRA1 | 1.74e-04 | 883 | 150 | 14 | C0036341 |
| Disease | beta-1,4-galactosyltransferase 1 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0801409 | |
| Disease | carbohydrate sulfotransferase 15 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0008066 | |
| Disease | CCL25 measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0010768 | |
| Disease | mannosyl-oligosaccharide 1,2-alpha-mannosidase IB measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0801783 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.30e-04 | 7 | 150 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | beta-1,4-galactosyltransferase 2 measurement | 5.30e-04 | 7 | 150 | 2 | EFO_0801410 | |
| Disease | Complement deficiency disease | 6.28e-04 | 33 | 150 | 3 | C0272242 | |
| Disease | Spinocerebellar Ataxia Type 2 | 6.86e-04 | 34 | 150 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 6.86e-04 | 34 | 150 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 6.86e-04 | 34 | 150 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 6.86e-04 | 34 | 150 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 6.86e-04 | 34 | 150 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 6.86e-04 | 34 | 150 | 3 | C0087012 | |
| Disease | CX3CL1 measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0009419 | |
| Disease | diastolic blood pressure, self reported educational attainment | 7.04e-04 | 8 | 150 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | Spinocerebellar Ataxia Type 4 | 7.48e-04 | 35 | 150 | 3 | C0752122 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 7.52e-04 | 80 | 150 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | lung carcinoma | 8.38e-04 | 482 | 150 | 9 | EFO_0001071 | |
| Disease | pulmonary function measurement, forced expiratory volume | 8.81e-04 | 37 | 150 | 3 | EFO_0003892, EFO_0004314 | |
| Disease | Small Lymphocytic Lymphoma | 1.12e-03 | 10 | 150 | 2 | C0855095 | |
| Disease | B-CELL MALIGNANCY, LOW-GRADE | 1.12e-03 | 10 | 150 | 2 | C1868683 | |
| Disease | autistic disorder (is_implicated_in) | 1.28e-03 | 42 | 150 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.72e-03 | 100 | 150 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Unipolar Depression | 2.16e-03 | 259 | 150 | 6 | C0041696 | |
| Disease | response to tenofovir | 2.24e-03 | 51 | 150 | 3 | EFO_0009279 | |
| Disease | unipolar depression, anxiety | 2.24e-03 | 14 | 150 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | indolelactate measurement | 2.24e-03 | 14 | 150 | 2 | EFO_0020012 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 2.58e-03 | 15 | 150 | 2 | EFO_0800301 | |
| Disease | Chronic Lymphocytic Leukemia | 2.78e-03 | 55 | 150 | 3 | C0023434 | |
| Disease | pneumonia (is_implicated_in) | 2.94e-03 | 16 | 150 | 2 | DOID:552 (is_implicated_in) | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 2.94e-03 | 16 | 150 | 2 | EFO_0800305 | |
| Disease | Bipolar Disorder | 3.14e-03 | 477 | 150 | 8 | C0005586 | |
| Disease | Antibody Deficiency Syndrome | 3.32e-03 | 17 | 150 | 2 | C0003257 | |
| Disease | C-X-C motif chemokine 16 measurement | 3.72e-03 | 18 | 150 | 2 | EFO_0010911 | |
| Disease | borna disease (biomarker_via_orthology) | 3.72e-03 | 18 | 150 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | Dyschondroplasias | 4.15e-03 | 19 | 150 | 2 | C0013366 | |
| Disease | rheumatoid arthritis, COVID-19 | 4.28e-03 | 64 | 150 | 3 | EFO_0000685, MONDO_0100096 | |
| Disease | Alcohol abuse | 4.86e-03 | 67 | 150 | 3 | C0085762 | |
| Disease | dehydroepiandrosterone sulphate measurement | 5.07e-03 | 68 | 150 | 3 | EFO_0007001 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IQIWSTPFFQEITDI | 1001 | Q8WWZ7 | |
| LNPRWNEVFEVIVTS | 696 | Q9BSJ8 | |
| EAVQEFTRTLPALVW | 191 | Q6NSW5 | |
| FNITLISEWVIPIRS | 191 | Q9NX77 | |
| WFQPDVLKNIITEII | 416 | Q8TDL5 | |
| LAPIVWEGTFNIDIL | 91 | P16442 | |
| VETVDRFQILTLWLP | 786 | P0C0L5 | |
| WLPFFTEREQTLQVL | 246 | Q9Y672 | |
| LQWVQLSAEEIPSRI | 631 | Q9UIF9 | |
| EVFWNTRIVPILREL | 266 | Q8NEN0 | |
| EILQLPNGALVWTFL | 3296 | Q86UQ4 | |
| LAENLWLPDIFIVES | 116 | Q8WXA8 | |
| LWFIIVISFLPNTEG | 11 | O95490 | |
| IWSFIGPVTFIILLN | 991 | O95490 | |
| IWPVLRNVETNFLGF | 186 | P49238 | |
| FQEPRTVVWLGVLSL | 106 | Q9NUS5 | |
| SVSELFAILRQWVPQ | 66 | Q8N3C7 | |
| EQLALEFQTWVVLSP | 191 | Q9H816 | |
| EFQTWVVLSPRRLEL | 196 | Q9H816 | |
| WEFFIIDPISGLIQT | 2661 | Q9H251 | |
| VIAPLSTIPNWEREF | 1021 | Q9P2D1 | |
| TVLEFSQLQVPLTWQ | 1146 | A6NNM3 | |
| TVLEFSQLQVPLTWQ | 1146 | A6NJZ7 | |
| TLSILISFIPVQLNW | 166 | P21918 | |
| VQAVKFEWNLESPLV | 761 | O75747 | |
| LFPINIWIFELERNV | 161 | Q2M2E3 | |
| IWIFELERNVSIPIG | 166 | Q2M2E3 | |
| FWVFQVILVAVPSAL | 76 | Q8NFK1 | |
| TWITEVILLGFQVDP | 6 | Q8NGT7 | |
| FTSSVIPQLLVNLWE | 76 | Q8NGZ5 | |
| VLEPVERVSTWVAFQ | 231 | Q96RG2 | |
| IEPLFQFSWLIVFLT | 491 | Q9ULH0 | |
| LTIWQIENFVPVLVE | 501 | Q13045 | |
| AIAWFIFTQEVLTPL | 176 | Q86YN1 | |
| NIIRGNLFPEVSIWI | 251 | Q7RTR2 | |
| EQLITLWVLFVFTIV | 51 | Q6W5P4 | |
| LVVLRFLVASADWPE | 241 | Q9H427 | |
| QLPDIALDVFALWLV | 66 | Q9BZ67 | |
| WAFLLPSDQRIDVEL | 1201 | Q6ZU64 | |
| QGTPWETLVVFAINL | 4396 | Q2LD37 | |
| LQFIFTWCLEIRAIP | 366 | Q9UBK8 | |
| IFTIVLTLPNFIFWT | 151 | P25089 | |
| SELLELFLQSPLVTW | 6 | Q9P219 | |
| VFLVWDPARLVLANI | 16 | P47869 | |
| ILSQVSFWLNRESVP | 266 | P47869 | |
| AFQTALWLLQPEVVF | 101 | Q53F39 | |
| LWLLQPEVVFILGDI | 106 | Q53F39 | |
| WDELIIFPIQISQLP | 741 | O00443 | |
| INSIIDPWVFAILRP | 306 | P43116 | |
| PNWVFQTLVITLIAV | 621 | Q96LU7 | |
| IIIQNTDLVEWSFLP | 351 | P63132 | |
| VFENPSIGVLELWVL | 96 | P62502 | |
| NTLELFDNWLTVIPS | 126 | Q9HBW1 | |
| ILSQVSFWLNRESVP | 291 | P34903 | |
| ILSQVSFWLNRESVP | 266 | P14867 | |
| TLLWAPTAQAEVLLQ | 11 | Q6UWW0 | |
| EENFLPWQRVISAVT | 686 | Q07075 | |
| WLVITIITVDRQPGF | 101 | Q9BRR3 | |
| LVVAVFQVLPQLLWD | 86 | P30559 | |
| RLAELVPFVTVNAQW | 261 | Q96P69 | |
| IIIQNTDLVEWSFLP | 351 | P63135 | |
| IIIQNTDLVEWSFLP | 351 | Q9BXR3 | |
| SEFTQWRRVIVLLPQ | 986 | P78509 | |
| QSSVSEFLLLDLPIW | 6 | Q8NGS1 | |
| NWVRNFVDSPIIVDI | 431 | P04062 | |
| LWLIFAAPTVEVNVS | 721 | Q5T6X5 | |
| DLAISINFWVPVLLN | 961 | Q13349 | |
| PVFVVQWLFDEAQLT | 331 | Q6P988 | |
| IIIQNTDLVEWSFLP | 351 | Q9QC07 | |
| ENALIVFTIWLAPSL | 41 | Q8NGX9 | |
| DFDLVPWLQIATQLI | 406 | Q13315 | |
| FLIIAPLSTIANWER | 911 | Q3L8U1 | |
| FDSLLWAIVTVFQIL | 906 | O43497 | |
| VLLVLLAQPFQSSEW | 281 | Q8WXQ3 | |
| LIVVIASLLFWVPFN | 241 | P51685 | |
| FRWSIDQLAVINPVE | 56 | Q6PGQ7 | |
| LQFALPDSLTTWEIQ | 786 | P01031 | |
| PIQNEESVVLFLVAW | 161 | B0YJ81 | |
| PISHVRFWVLQIIFV | 71 | P17302 | |
| RFWVLQIIFVSVPTL | 76 | P17302 | |
| RWPEEALLIVANSFL | 2171 | Q0VDD8 | |
| VWPVPENIEITVTLF | 71 | Q8NDI1 | |
| DVRILNPLDSWVSFL | 266 | Q92839 | |
| LQAVSPSRIWNFVEI | 416 | Q9NWL6 | |
| VSLAVVTEFAWVLAP | 31 | Q96LL3 | |
| ALEAIVQLWRIPSFV | 521 | Q92538 | |
| VQVIPWVLADSNFVR | 406 | Q9BZB8 | |
| WIQIDVTSLLQPLVA | 211 | O60383 | |
| VIWNAVKFPEILATL | 156 | P54198 | |
| TTIPELFAIVRQWVP | 76 | Q96DZ5 | |
| EAVQEFTRTLPALVW | 191 | Q8TCE6 | |
| RDWTLLQLVVSVPFF | 256 | Q96S37 | |
| EIPFSLVQFPLWESL | 151 | Q70HW3 | |
| IIPALSNWEQILYVT | 206 | Q13895 | |
| SVIFIFVFLWTPVLD | 261 | Q6N075 | |
| VETVDRFQILTLWLP | 786 | P0C0L4 | |
| SLVRVNWEIFTPLRA | 421 | Q5VWM6 | |
| NDSFPAWAIVIVVLV | 441 | Q3MIW9 | |
| TSDPQWQVVLFIFLL | 16 | A6NL08 | |
| EFILLVFSDQPWLEI | 11 | Q9GZK3 | |
| EVPSRVQEIWQEFLA | 376 | P49802 | |
| RLPSWQVALLTSVVF | 116 | Q8N4V2 | |
| LNSLQLVSEWRPVVE | 936 | Q6YHU6 | |
| EISNRALINVWIPSV | 651 | Q8TEQ0 | |
| AWPLLETVFSEVLTR | 571 | Q96DN5 | |
| IIVSQGWVLIDFLLF | 191 | Q969N4 | |
| WAIFQEQTVVLQVRP | 211 | A6NGB0 | |
| APVVQLLIEQFSWRG | 191 | Q6ZSM3 | |
| VDLSSIWIFIPQLFV | 496 | Q86VW1 | |
| NDLSWFQSITRLPII | 206 | Q9NYQ3 | |
| TENPFVQLLSGVVWL | 191 | Q9UK23 | |
| FPSWRVLIQDLVLEG | 191 | Q9NUX5 | |
| LLVVVPSSVRFTWEQ | 481 | Q9NZC9 | |
| EKIIAVAWDIFQPLL | 386 | Q86UD5 | |
| ELIAKIPNFWVTTFV | 86 | Q01105 | |
| PDFILWEQRTVVLQG | 1111 | Q9UKZ4 | |
| SLVRVNWEIFTPLRA | 421 | O95521 | |
| LNTWPIIRDLVDDIF | 246 | Q9GZT4 | |
| LISPINVSLNFSLWE | 721 | P20701 | |
| SLVRVNWEIFTPLRA | 421 | O60811 | |
| WLPFFTVNIVNLAVA | 261 | P35346 | |
| PWLLNATVEENIIFE | 776 | Q09428 | |
| VLQWVAASELNVPIL | 776 | O75969 | |
| WPLLDIINSLVTTVF | 76 | Q9UBR5 | |
| PELQVNGFVLIIDWS | 151 | Q5SYC1 | |
| DFFNWLSVLVLLPVE | 221 | O95436 | |
| IIIQNTDLVEWSFLP | 351 | P63136 | |
| EVWVSGTIFIRNVLL | 146 | Q86VR2 | |
| SWLEPVQLLRSVFAN | 111 | P01242 | |
| TVLNLPTRVIVVWFQ | 2216 | Q86UP3 | |
| IQWPSREFSVPEIIA | 466 | P17643 | |
| ITEQFVADPRLTLWR | 386 | Q9P217 | |
| QFLTILPEELQAWVR | 111 | Q53GI3 | |
| QFLTILPEELQAWVR | 86 | Q96LW9 | |
| IALVVSLIILFQFWQ | 176 | Q9BYE2 | |
| LEQFLTILPREVQTW | 96 | P17040 | |
| ALTLLPESRIQVWFQ | 121 | Q9H2W2 | |
| QWVFDSVNARLLLPV | 396 | O00541 | |
| LFRWEQDEIPSSLIL | 211 | O60673 | |
| GLVWTIILRFQIQDI | 151 | O15020 | |
| LLTVVLRVQFPSWNG | 506 | O43511 | |
| ISIWDIRILPNFNAS | 251 | Q8WVR3 | |
| LVVWIEDQTSRNIPL | 86 | Q96MW7 | |
| WIIQVPILASIVLNF | 361 | Q03431 | |
| WILRINLVAAIFSAP | 616 | Q9BQI7 | |
| IIIQNTDLVEWSFLP | 351 | P10266 | |
| IIIQNTDLVEWSFLP | 351 | P63133 | |
| FLLEWTLQPISQFVE | 421 | Q6ZS81 | |
| IIIQNTDLVEWSFLP | 351 | Q9UQG0 | |
| EQFPTVLLQEIQIWV | 91 | Q9GZW5 | |
| SQEFLLPDVIRIWDS | 326 | Q9NVG8 | |
| QFQVPWLESVLIVVS | 341 | Q6XQN6 | |
| LQFIDWILRGISQVV | 56 | Q13336 | |
| TLLPEDFNLIVNWST | 571 | Q8NEG5 | |
| AVSQLWLAVVVVPLA | 36 | P0C7T8 | |
| VIAEIWFPVADATRI | 321 | Q9HBG4 | |
| FLTILPGNLQSWVRE | 101 | Q969J2 | |
| EQFLSILPGELRVWV | 101 | P59923 | |
| EQFLSILPEELQIWV | 96 | Q8NF99 | |
| TLTANIIWFPDNFLI | 351 | Q2M389 | |
| FLAILPEEVRTWVNL | 96 | Q9UL58 | |
| EQFLTILPEKIQAWA | 91 | Q63HK3 | |
| QFLSILPGELRTWVQ | 101 | Q9P0L1 | |
| LNWVFVVIFTLECLI | 1401 | Q9UI33 | |
| WNTLEFFILVIGIID | 671 | Q5TAH2 | |
| VVPWNVTLFSLLVAA | 151 | O14894 | |
| FLTVLPGEIQNWVQE | 66 | Q8IWY8 | |
| DNSIIWTPIALTVFL | 166 | Q6ZXV5 | |
| QVITISPSEFRWAEL | 106 | Q9BXE9 | |
| PVDVNSAAFRLWQIL | 1291 | O75093 | |
| LEQFLTILPEELQAW | 91 | O43309 | |
| LVITWPFSILDQAVD | 361 | Q6ZQQ6 | |
| ESVIWEITPPALFRQ | 251 | P0DJG4 | |
| NVVPWNLTLFSILLV | 151 | P48230 | |
| ITQTLNPVWDETFIL | 176 | Q70J99 | |
| QWATTILDIERSFPV | 736 | Q9HBA0 | |
| PFLTAFQLSWELQEL | 216 | Q9UBN4 | |
| FLTILPEELQAWVRQ | 96 | Q3MJ62 | |
| RWTVRLDISAPQVIF | 706 | Q5THJ4 | |
| ITLQTWVVILDFFGI | 1821 | Q5THJ4 | |
| PGVVQVWEALLTLVF | 221 | Q9UPR5 |